Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of EUR 44.87 million. The enterprise value is 56.82 million.

Market Cap	44.87M
Enterprise Value	56.82M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	23.98M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.09%
Owned by Institutions (%)	31.30%
Float	21.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	50.36
PS Ratio	0.94
PB Ratio	1.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	21.95
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-28.57
EV / Sales	1.13
EV / EBITDA	13.39
EV / EBIT	39.23
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.62.

Current Ratio	1.55
Quick Ratio	0.83
Debt / Equity	0.62
Debt / EBITDA	4.37
Debt / FCF	n/a
Interest Coverage	0.58

Financial Efficiency

Return on equity (ROE) is -8.55% and return on invested capital (ROIC) is 3.47%.

Return on Equity (ROE)	-8.55%
Return on Assets (ROA)	1.68%
Return on Invested Capital (ROIC)	3.47%
Return on Capital Employed (ROCE)	2.87%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.14M
Profits Per Employee	-47,350
Employee Count	42
Asset Turnover	0.94
Inventory Turnover	3.48

Taxes

In the past 12 months, Navamedic ASA has paid 665,852 in taxes.

Income Tax	665,852
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.10% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.10%
50-Day Moving Average	1.91
200-Day Moving Average	1.88
Relative Strength Index (RSI)	43.43
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of EUR 47.77 million and -1.99 million in losses.

Revenue	47.77M
Gross Profit	18.61M
Operating Income	1.37M
Pretax Income	-1.32M
Net Income	-1.99M
EBITDA	4.02M
EBIT	1.37M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 6.27 million in cash and 17.59 million in debt, with a net cash position of -11.33 million.

Cash & Cash Equivalents	6.27M
Total Debt	17.59M
Net Cash	-11.33M
Net Cash Per Share	n/a
Equity (Book Value)	28.23M
Book Value Per Share	n/a
Working Capital	8.18M

Full Balance Sheet

Cash Flow

Operating Cash Flow	2.04M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 38.97%, with operating and profit margins of 2.87% and -4.16%.

Gross Margin	38.97%
Operating Margin	2.87%
Pretax Margin	-2.77%
Profit Margin	-4.16%
EBITDA Margin	8.42%
EBIT Margin	2.87%
FCF Margin	n/a

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.43%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5